(Q36169364)

12 August 2017

title

Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease (English)

1 reference

12 August 2017

1 reference

7

R Storb

1 reference

12 August 2017

8

M E D Flowers

1 reference

12 August 2017

L Giaccone

1

1 reference

12 August 2017

P Martin

2

1 reference

12 August 2017

P Carpenter

3

1 reference

12 August 2017

C Moravec

4

1 reference

12 August 2017

H Hooper

5

1 reference

12 August 2017

V A M Funke

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

12 August 2017

number of pages

5

1 reference

Bone Marrow Transplantation

inferred from page(s)

published in

1 reference

12 August 2017

volume

36

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

337-341

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705022

12 August 2017

exact match

0 references

cites work

Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

A survey of diagnosis, management, and grading of chronic GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

Molecular action of methotrexate in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

Chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

7 January 2021

Low Dose Methotrexate in Inflammatory Bowel Disease: Current Status and Future Directions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

7 January 2021

Efficacy of low-dose methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

7 January 2021

Methotrexate revisited: effects of long-term treatment in psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

7 January 2021

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

7 January 2021

Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705022

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705022

1 reference

12 August 2017

1 reference